BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1617 related articles for article (PubMed ID: 34976920)

  • 41. Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore.
    Kim S; Goh Y; Kang JHB
    Global Health; 2022 Sep; 18(1):82. PubMed ID: 36131348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of China's Paired Assistance Policy on the COVID-19 Crisis-An Empirical Case Study of Hubei Province.
    Huang R; Yao X; Chen Z; Li W; Yan H
    Front Public Health; 2022; 10():885852. PubMed ID: 35712299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk Perception and Depression in Public Health Crises: Evidence from the COVID-19 Crisis in China.
    Ding Y; Xu J; Huang S; Li P; Lu C; Xie S
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784792
    [No Abstract]   [Full Text] [Related]  

  • 44. Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of China's Prevention and Control Strategy for the COVID-19 Epidemic.
    Wang J; Wang Z
    Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32225019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Policy Disparities in Response to COVID-19 between China and South Korea.
    Chen H; Shi L; Zhang Y; Wang X; Sun G
    J Epidemiol Glob Health; 2021 Jun; 11(2):246-252. PubMed ID: 33876595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How China controls the Covid-19 epidemic through public health expenditure and policy?
    Jin H; Li B; Jakovljevic M
    J Med Econ; 2022; 25(1):437-449. PubMed ID: 35289700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic Policy Uncertainty (EPU) and China's Export Fluctuation in the Post-pandemic Era: An Empirical Analysis based on the TVP-SV-VAR Model.
    Hu G; Liu S
    Front Public Health; 2021; 9():788171. PubMed ID: 34938713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Appraisal of China's Response to the Outbreak of COVID-19 in Comparison With SARS.
    Li J; Li S; Cao W; Wang Z; Liang Z; Fu W; Zhao J
    Front Public Health; 2021; 9():679540. PubMed ID: 34307279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Social Media Use for Health Communication by the CDC in Mainland China: National Survey Study 2009-2020.
    Zeng R; Li M
    J Med Internet Res; 2020 Dec; 22(12):e19470. PubMed ID: 33151892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Impact of China's Legal System on Public Health and Quality of Life during the COVID-19 Pandemic: An Empirical Study.
    Duan W; Qin T
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of political disagreements and corruption on state health leader turnover during the COVID-19 pandemic in Brazil.
    Barberia LG; Masiero G; Alves de Lima I; Santana L; Moraes de Sousa TC
    Leadersh Health Serv (Bradf Engl); 2024 Jun; ahead-of-print(ahead-of-print):. PubMed ID: 38884379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Citywide 'Virus Testing': Chinese Government's Response to Preventing and Controlling the Second Outbreak of SARS-CoV-2.
    Zhou L; Seesaghur HN; Akhtar N; Boolakee J; Pratt CB
    Front Public Health; 2021; 9():601592. PubMed ID: 34222164
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigating the Self-Reported Health Status of Domestic and Overseas Chinese Populations during the COVID-19 Pandemic.
    Mao Z; Chen B; Wang W; Kind P; Wang P
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33809532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The governance of imported 2019-nCov infections: What can be learned from China's experience?
    Li H; He J; Chen J; Pan S; Feng J; Liu S
    Glob Health Res Policy; 2022 Mar; 7(1):8. PubMed ID: 35264241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Managing COVID-19 within and across health systems: why we need performance intelligence to coordinate a global response.
    Kringos D; Carinci F; Barbazza E; Bos V; Gilmore K; Groene O; Gulácsi L; Ivankovic D; Jansen T; Johnsen SP; de Lusignan S; Mainz J; Nuti S; Klazinga N;
    Health Res Policy Syst; 2020 Jul; 18(1):80. PubMed ID: 32664985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 Crisis Management: Lessons From the United Arab Emirates Leaders.
    Abbas Zaher W; Ahamed F; Ganesan S; Warren K; Koshy A
    Front Public Health; 2021; 9():724494. PubMed ID: 34778167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 Control: Can Germany Learn From China?
    Müller O; Lu G; Jahn A; Razum O
    Int J Health Policy Manag; 2020 Oct; 9(10):432-435. PubMed ID: 32610735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of a psychological intervention mechanism for healthcare workers facing public health emergencies in the context of the COVID-19 outbreak.
    Zhang X; Sun F; Wang Y; Zhu Z
    Int J Health Plann Manage; 2021 Nov; 36(6):2424-2429. PubMed ID: 34405456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Schistosomiasis control in the evolution of China's international discourse power].
    Zhou LY; Zhang JF; Li W; Yang K
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2021 Oct; 33(5):518-522. PubMed ID: 34791852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concerns Expressed by Chinese Social Media Users During the COVID-19 Pandemic: Content Analysis of Sina Weibo Microblogging Data.
    Wang J; Zhou Y; Zhang W; Evans R; Zhu C
    J Med Internet Res; 2020 Nov; 22(11):e22152. PubMed ID: 33151894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.